Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
11 Oct 2024 |
CS01 |
Confirmation statement made on 11 October 2024 with no updates
|
|
|
11 Oct 2024 |
PSC05 |
Change of details for Gsk Finance (No 2) Limited as a person with significant control on 11 October 2024
|
|
|
20 Sep 2024 |
CH01 |
Director's details changed for Mrs Demet Gurunlu Russ on 15 July 2024
|
|
|
17 Sep 2024 |
CH01 |
Director's details changed for Mrs Laura Guittard on 11 September 2024
|
|
|
17 Sep 2024 |
CH01 |
Director's details changed for Mrs Demet Gurunlu Russ on 11 September 2024
|
|
|
11 Sep 2024 |
PSC05 |
Change of details for Gsk Finance (No 2) Limited as a person with significant control on 11 September 2024
|
|
|
11 Sep 2024 |
AD01 |
Registered office address changed from , 980 Great West Road, Brentford, Middlesex, TW8 9GS, England to 79 New Oxford Street London WC1A 1DG on 11 September 2024
|
|
|
18 Jul 2024 |
AD02 |
Register inspection address has been changed from 980 Great West Road Brentford TW8 9GS England to 79 New Oxford Street London WC1A 1DG
|
|
|
11 Jul 2024 |
AP01 |
Appointment of Mrs Demet Gurunlu Russ as a director on 25 June 2024
|
|
|
05 Jul 2024 |
TM01 |
Termination of appointment of Jill Dawn Anderson as a director on 25 June 2024
|
|
|
21 May 2024 |
AA |
Audit exemption subsidiary accounts made up to 31 December 2023
|
|
|
21 May 2024 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 31/12/23
|
|
|
21 May 2024 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 31/12/23
|
|
|
21 May 2024 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 31/12/23
|
|
|
11 Oct 2023 |
CS01 |
Confirmation statement made on 11 October 2023 with no updates
|
|
|
22 Aug 2023 |
AA |
Audit exemption subsidiary accounts made up to 31 December 2022
|
|
|
22 Aug 2023 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 31/12/22
|
|
|
22 Aug 2023 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 31/12/22
|
|
|
16 Aug 2023 |
CH02 |
Director's details changed for Glaxo Group Limited on 6 June 2023
|
|
|
07 Aug 2023 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 31/12/22
|
|
|
03 Mar 2023 |
AP01 |
Appointment of Ms Jill Anderson as a director on 1 March 2023
|
|
|
02 Mar 2023 |
TM01 |
Termination of appointment of Jerome Charles Maurice Andries as a director on 1 March 2023
|
|
|
05 Oct 2022 |
CS01 |
Confirmation statement made on 5 October 2022 with no updates
|
|
|
21 Jun 2022 |
AA |
Audit exemption subsidiary accounts made up to 31 December 2021
|
|
|
21 Jun 2022 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 31/12/21
|
|